Cross Country Healthcare, Inc. (CCRN)
Quantitative Summary
DeterministicFinancial health is average: Piotroski 5/9.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
DCF Sandbox
InteractiveSensitivity Matrix
| TG ↓ / WACC → | 8% | 10% | 12% |
|---|---|---|---|
| 2% | $19 | $15 | $13 |
| 3% | $22 | $17 | $14 |
| 4% | $25 | $18 | $15 |
Center = base case. Green = >10% upside, Red = >10% downside vs —.
Pre-computed DCF: WACC=10.0%, terminal growth 3%. Fair value $17 (+0.0%). Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
Balance Sheet Health
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
ETF Contagion Visualizer
Simulate a price drop in Cross Country Healthcare, Inc. to visualize passive redemption contagion across ETFs and collateral stocks.
If Cross Country Healthcare, Inc. (CCRN) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Eli Lilly & Co. (LLY) as the most exposed collateral stock, sharing 2 ETFs with CCRN. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 2 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
CCRN Ownership Dynamics
ETFs with Highest CCRN Exposure
Float lock-up computed from 2 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-11 | 1,406 | $13.18 | $18,531.08 |
| 2026-05-08 | 374,234 | $13.09 | $4.9M |
| 2026-04-30 | 3,162 | $10.27 | $32,473.74 |
| 2026-04-28 | 29,598 | $10.30 | $304,859.4 |
| 2026-04-24 | 234 | $9.96 | $2,330.64 |
| 2026-04-06 | 17,438 | $9.18 | $160,080.84 |
| 2026-03-23 | 4,516 | $9.18 | $41,456.88 |
| 2026-03-19 | 384 | $8.86 | $3,402.24 |
| 2026-03-17 | 32,893 | $9.14 | $300,642.02 |
| 2026-03-12 | 12,564 | $9.78 | $122,875.92 |
| 2026-03-10 | 268 | $10.06 | $2,696.08 |
| 2026-03-02 | 1,317 | $8.70 | $11,457.9 |
| 2026-02-27 | 5,395 | $8.77 | $47,314.15 |
| 2026-02-26 | 16,085 | $8.93 | $143,639.05 |
| 2026-02-18 | 130 | $8.22 | $1,068.6 |
| 2026-02-13 | 23 | $7.95 | $182.85 |
| 2026-02-03 | 1,287 | $9.23 | $11,879.01 |
| 2026-01-26 | 51 | $9.02 | $460.02 |
| 2026-01-05 | 1,213 | $8.06 | $9,776.78 |
| 2025-12-30 | 2,398 | $8.20 | $19,663.6 |
| 2025-12-22 | 43 | $7.95 | $341.85 |
| 2025-12-15 | 2 | $8.49 | $16.98 |
| 2025-12-11 | 1,973 | $8.16 | $16,099.68 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Compare CCRN to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.